From medicine to markets: Long-term biotech investing

Capital Ideas Investing Podcast by Capital Group

May 14, 202620:31Business

Biotech investing often hinges on understanding science, trials and patient outcomes. Dr. Judith Finegold is a physician turned equity analyst, and she explains how her clinical experience helps assess drug pipelines, cl...

Related Episodes

Continue listening to more episodes from Capital Ideas Investing Podcast.

Luxury, mining and the power of connecting the dots

Sep 17, 2026 - 30:00

From advising Canada's finance minister to researching companies across luxury and mining industries, Cap...

Bond talk: Which way interest rates?

Sep 10, 2026 - 34:25

Capital Group fixed income manager John Queen discusses his outlook for the U.S. bond market as concerns...

NFL Colts QB Daniel Jones on quiet leadership

Sep 3, 2026 - 25:03

If there's one thing quarterback Daniel Jones has learned across three National Football League (NFL) tea...

Market leadership: U.S. vs international stocks

Aug 27, 2026 - 31:22

Capital Group portfolio managers Lisa Thompson and Diana Wagner discuss the merits of U.S., international...

Investing through the AI transition

Aug 20, 2026 - 25:59

Equity portfolio manager Brady Enright invested through the dot-com era and is now navigating another per...

The next wave of defense spending

Aug 13, 2026 - 25:19

Capital Group equity analysts Zach Alexander and Caroline Janin discuss their outlook for the $2.7 trilli...

Who you become when you invest

Aug 6, 2026 - 23:27

For Greg Miliotes, portfolio manager and Investment Group Oversight Chair, becoming an investor isn't abo...

8 book recommendations for your summer reading list

Jul 30, 2026 - 09:01

Looking for some great reading material on a hot summer day? We've got you covered. Here are eight compel...